athenahealth Inc. (NASDAQ:ATHN) Director Brandon H. Hull sold 2,400 shares of the stock in a transaction on Monday, October 10th. The shares were sold at an average price of $130.00, for a total value of $312,000.00. Following the transaction, the director now directly owns 3,987 shares of the company’s stock, valued at $518,310. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

athenahealth Inc. (NASDAQ:ATHN) opened at 126.93 on Wednesday. The stock has a 50 day moving average price of $123.54 and a 200 day moving average price of $129.76. The stock has a market cap of $4.99 billion, a P/E ratio of 466.65 and a beta of 1.28. athenahealth Inc. has a 12-month low of $114.59 and a 12-month high of $170.42.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings data on Thursday, July 21st. The company reported $0.34 EPS for the quarter, missing the consensus estimate of $0.42 by $0.08. The company earned $261.90 million during the quarter, compared to analysts’ expectations of $274.07 million. athenahealth had a return on equity of 5.16% and a net margin of 1.06%. On average, analysts forecast that athenahealth Inc. will post $1.77 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

A number of equities analysts have recently commented on the company. Zacks Investment Research lowered athenahealth from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 12th. FBR & Co cut their price target on athenahealth from $145.00 to $140.00 and set a “market perform” rating for the company in a report on Friday, July 22nd. Deutsche Bank AG lowered athenahealth from a “buy” rating to a “hold” rating and cut their price target for the stock from $165.00 to $147.00 in a report on Friday, July 22nd. Canaccord Genuity reaffirmed a “hold” rating and issued a $142.00 price target on shares of athenahealth in a report on Wednesday, June 29th. Finally, Leerink Swann reaffirmed a “hold” rating on shares of athenahealth in a report on Thursday, June 16th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have issued a buy rating to the company. athenahealth has an average rating of “Hold” and a consensus price target of $149.70.

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Glenmede Trust Co. NA increased its position in shares of athenahealth by 66.3% in the first quarter. Glenmede Trust Co. NA now owns 6,253 shares of the company’s stock valued at $867,000 after buying an additional 2,492 shares in the last quarter. Aperio Group LLC increased its position in shares of athenahealth by 11.6% in the first quarter. Aperio Group LLC now owns 3,429 shares of the company’s stock valued at $476,000 after buying an additional 357 shares in the last quarter. Pacad Investment Ltd. purchased a new position in shares of athenahealth during the first quarter valued at $222,000. Franklin Resources Inc. increased its position in shares of athenahealth by 10.8% in the first quarter. Franklin Resources Inc. now owns 544,811 shares of the company’s stock valued at $75,609,000 after buying an additional 53,300 shares in the last quarter. Finally, BlackRock Inc. increased its position in shares of athenahealth by 273.8% in the first quarter. BlackRock Inc. now owns 4,508 shares of the company’s stock valued at $625,000 after buying an additional 3,302 shares in the last quarter.

About athenahealth

athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.

5 Day Chart for NASDAQ:ATHN

Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.